ASCO 2022 Conference Coverage


 

ASCO 2022 on TROPION-Lung08: Dato-DXd + Pembro in Treatment-Naïve Advanced/Metastatic NSCLC With PD-L1 ≥ 50% and Without Actionable Genomic Alterations

131 views
June 10, 2022
Comments 0
Login to view comments. Click here to Login